These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 22387030)

  • 21. [Echo-guided radiofrequency percutaneous ablation of hepatocellular carcinoma in cirrhosis using a cooled needle].
    Marone G; Francica G; D'Angelo V; Iodice G; Pastore P; Altamura G; Cusati B; Siani A
    Radiol Med; 1998 Jun; 95(6):624-9. PubMed ID: 9717546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
    Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
    J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
    Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
    J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound.
    Song KD; Lee MW; Rhim H; Cha DI; Chong Y; Lim HK
    AJR Am J Roentgenol; 2013 Nov; 201(5):1141-7. PubMed ID: 24147489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
    Woo S; Lee JM; Yoon JH; Joo I; Kim SH; Lee JY; Yoon JH; Kim YJ; Han JK; Choi BI
    Radiology; 2013 Aug; 268(2):589-600. PubMed ID: 23513241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local tumour progression after loco-regional therapy of hepatocellular carcinomas: value of fusion imaging-guided radiofrequency ablation.
    Min JH; Lee MW; Rhim H; Cha DI; Lim S; Choi SY; Lim HK
    Clin Radiol; 2014 Mar; 69(3):286-93. PubMed ID: 24332169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors predicting complete necrosis rate after ultrasound-guided percutaneous laser thermoablation of small hepatocellular carcinoma tumors in cirrhotic patients: a multivariate analysis.
    Francica G; Iodice G; Delle Cave M; Sarrantonio R; Lapiccirella G; Molese V; Smeraldo D; Scarano F; De Marino F
    Acta Radiol; 2007 Jun; 48(5):514-9. PubMed ID: 17520427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
    Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.
    Llovet JM; Vilana R; Brú C; Bianchi L; Salmeron JM; Boix L; Ganau S; Sala M; Pagès M; Ayuso C; Solé M; Rodés J; Bruix J;
    Hepatology; 2001 May; 33(5):1124-9. PubMed ID: 11343240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
    Du J; Li HL; Zhai B; Chang S; Li FH
    Ultrasound Med Biol; 2015 Sep; 41(9):2400-11. PubMed ID: 26055968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous radiofrequency ablation with internally cooled versus internally cooled wet electrodes for small subphrenic hepatocellular carcinomas.
    Kim JH; Kim PN; Won HJ; Shin YM
    J Vasc Interv Radiol; 2013 Mar; 24(3):351-6. PubMed ID: 23433411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma.
    Giorgio A; Tarantino L; de Stefano G; Scala V; Liorre G; Scarano F; Perrotta A; Farella N; Aloisio V; Mariniello N; Coppola C; Francica G; Ferraioli G
    AJR Am J Roentgenol; 2003 Aug; 181(2):479-84. PubMed ID: 12876030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
    Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
    Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.
    Choi D; Lim HK; Rhim H; Kim YS; Yoo BC; Paik SW; Joh JW; Park CK
    Ann Surg Oncol; 2007 Aug; 14(8):2319-29. PubMed ID: 17522947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography.
    Rhim H; Choi D; Kim YS; Lim HK; Choe BK
    Eur J Radiol; 2010 Aug; 75(2):253-8. PubMed ID: 19427152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency ablation for recurrent hepatocellular carcinoma in postresectional patients: prognostic factors analysis.
    Lin YH; Chiou YY; Chou YH; Chau GY; Wang HK; Chiang JH; Chang CY
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1239-44. PubMed ID: 21941191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.
    Darnell A; Forner A; Rimola J; Reig M; García-Criado Á; Ayuso C; Bruix J
    Radiology; 2015 Jun; 275(3):698-707. PubMed ID: 25658038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.